Official SEC submissions

Enliven Therapeutics SEC Filings

Direct answer

Enliven Therapeutics's latest SEC filing is 144.

It was filed on September 17, 2026, and 40 recent filings are available.

Each row links directly to the SEC document and filing index.

Official SEC EDGAR submissions

Get free Enliven Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

144

Planned securities sale

Filed: 2026-09-17

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-09-04

Open SEC document View filing index

Insider transaction

Filed: 2026-08-19

Report date: 2026-08-17

Open SEC document View filing index

Insider transaction

Filed: 2026-08-19

Report date: 2026-08-17

Open SEC document View filing index

Insider transaction

Filed: 2026-08-06

Report date: 2026-08-04

Open SEC document View filing index

10-Q

Periodic report

Filed: 2026-08-05

Report date: 2026-06-30

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2026-08-05

Report date: 2026-08-05

8-K

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-08-04

Open SEC document View filing index

Insider transaction

Filed: 2026-07-21

Report date: 2026-07-17

Open SEC document View filing index

Insider transaction

Filed: 2026-07-21

Report date: 2026-07-17

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-07-17

Open SEC document View filing index

Insider transaction

Filed: 2026-07-08

Report date: 2026-07-06

Open SEC document View filing index

Insider transaction

Filed: 2026-06-24

Report date: 2026-06-22

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-06-22

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-06-22

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-06-22

Open SEC document View filing index

Insider transaction

Filed: 2026-06-22

Report date: 2026-06-17

Open SEC document View filing index

Insider transaction

Filed: 2026-06-22

Report date: 2026-06-17

Open SEC document View filing index

Insider transaction

Filed: 2026-06-17

Report date: 2026-06-15

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-06-17

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-06-15

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-06-15

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-06-15

Open SEC document View filing index

8-K

Current report

Filed: 2026-06-12

Report date: 2026-06-11

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-06-11

Report date: 2026-06-11

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-06-10

Report date: 2026-06-09

8-K

Open SEC document View filing index

Insider transaction

Filed: 2026-06-09

Report date: 2026-06-05

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-06-05

Open SEC document View filing index

Insider transaction

Filed: 2026-05-20

Report date: 2026-05-18

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-05-18

Open SEC document View filing index

10-Q

Periodic report

Filed: 2026-05-07

Report date: 2026-03-31

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2026-05-07

Report date: 2026-05-07

8-K

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-04-30

Open SEC document View filing index

DEFA14A

Proxy statement

Filed: 2026-04-27

DEFA14A

Open SEC document View filing index

DEF 14A

Proxy statement

Filed: 2026-04-27

Report date: 2026-06-09

DEF 14A

Open SEC document View filing index

Insider transaction

Filed: 2026-04-21

Report date: 2026-04-17

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-03-31

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-03-31

Open SEC document View filing index

Insider transaction

Filed: 2026-03-27

Report date: 2026-03-25

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-03-25

Open SEC document View filing index

Verified data

Recent filing categories: 5
Recent filings: 40
SEC CIK: 0001672619
Latest filing date: September 17, 2026

Explore related company data

View the Enliven Therapeutics company profile View Enliven Therapeutics annual financials